| abstract |
The present invention provides a method of treating an individual suffering from active lupus nephritis comprising the step of periodically administering to a subject in an amount effective to treat the individual, or a pharmaceutically acceptable salt thereof, do. The present invention also provides a rquinimodem or a pharmaceutically acceptable salt thereof for use in the treatment of an individual suffering from active lupus nephritis. In addition, the present invention provides a pharmaceutical composition comprising an amount of a Racinis mode or a pharmaceutically acceptable salt thereof for use in the treatment of an individual suffering from active lupus nephritis. |